Choosing the right radiopharmaceutical CRO can make or break your clinical trial. When every minute counts, you need a partner who knows the stakes. Radiopharmaceutical clinical trials stand as some of the most complex studies in drug development today. These trials go beyond standard oncology studies, demanding strict adherence to specialized handling procedures, accommodating short half-life products, and requiring precise coordination across multiple stakeholders. For sponsors, this means your CRO selection isn't merely about finding a service provider, it's about securing a strategic partner who can navigate these challenges while ensuring speed, compliance, and site readiness. Through our experience managing radiopharmaceutical trials, we've learned that success requires a fundamentally different approach from traditional oncology studies. With some imaging agents having half-lives as short as 20 minutes, a single delayed delivery can compromise an entire day of patient procedures. Here's what sponsors should look for when evaluating potential partners.